Cited by — In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y.
No admitted local citation edges point to this work yet.
